Target intelligence / Profile preview

Transmembrane AMPA receptor regulatory protein gamma-8-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (TARP γ-8-AMPAR)

Target
TARP γ-8-AMPAR
Molecular classification
Ionotropic glutamate receptor, Ligand-gated ion channel, Protein complex
01

Overview

TARP γ-8-containing AMPA-type glutamate receptors are specialized ionotropic receptor complexes where the core AMPA receptor (AMPAR) is associated with the auxiliary subunit Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8, encoded by the CACNG8 gene (UniProt Q8WXS5). These complexes are primarily responsible for mediating fast excitatory synaptic transmission in the central nervous system, with γ-8 specifically regulating the trafficking, surface expression, and gating kinetics of the receptor (Kato et al., 2016, Nature). A defining characteristic of the γ-8 subunit is its highly enriched expression in the hippocampus compared to its sparse distribution in the cerebellum and other brain regions. This regional specificity has made the γ-8-AMPAR complex a primary target for the development of site-specific anticonvulsants, such as LY3130481 (Ceremane), which act as selective negative allosteric modulators (Maher et al., 2017, CNS Drugs). By targeting the γ-8-associated pool of receptors, these drugs aim to suppress hippocampal hyperexcitability in epilepsy patients while avoiding the global neurological side effects, such as ataxia and sedation, typically seen with non-selective AMPAR antagonists like perampanel.

Other names
CACNG8-associated AMPA receptorgamma-8-containing AMPA receptorTARP gamma-8-AMPAR complexgamma-8-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
02

Mechanism of action

Selective negative allosteric modulation of AMPA receptors associated with the TARP gamma-8 auxiliary subunit.

03

Biological functions

Excitatory synaptic transmissionSynaptic plasticityAMPA receptor traffickingModulation of channel gating
04

Disease associations

EpilepsySeizure disorders
05

Safety considerations

Potential for cognitive impairmentMemory deficitsPsychiatric side effects
06

Interacting drugs

LY3130481 (Ceremane)

1 more in the full profile.

07

Biomarkers

CACNG8 mRNA/protein expressionHippocampal seizure activity via EEG

Beyond the preview

Go deeper on Transmembrane AMPA receptor regulatory protein gamma-8-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (TARP γ-8-AMPAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane AMPA receptor regulatory protein gamma-8-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (TARP γ-8-AMPAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call